---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-025420"
form_type: "8-K"
ticker: "ACRS"
cik: "0001557746"
company_name: "Aclaris Therapeutics, Inc."
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T16:37:06.387880+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aclaris Therapeutics raises $39.8M via ATM offering of 12.7M shares

## Summary
- Sold 12.7 million shares for gross proceeds of $39.8M under ATM agreement from March 2-9, 2026.
- Shares purchased by institutional investors including Deep Track Capital.
- Sales executed by agents Leerink Partners and Cantor Fitzgerald.

## SEC filing metadata
- accession: 0001104659-26-025420
- form_type: 8-K
- ticker: ACRS
- cik: 0001557746
- company_name: Aclaris Therapeutics, Inc.
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557746/000110465926025420/0001104659-26-025420-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557746/000110465926025420/acrs-20260309x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-025420
- JSON: https://secwatch.observer/filing/0001104659-26-025420.json
- Plain text: https://secwatch.observer/filing/0001104659-26-025420.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.